Company
Nacuity Pharmaceuticals, Inc.
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Nacuity Pharmaceuticals, Inc. is a biopharmaceutical company that has acquired certain rights to, and is developing, NACA, a small molecule antioxidant for the treatment of retinitis pigmentosa and potentially other retinal-based diseases.
Loading relationship preview